Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Dyslipidemias Clinical Trials

11 recruiting trials for Dyslipidemias. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
11
Total Trials
11
Recruiting Now
1
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGPhase 4NCT06186037

Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy...

\[Purpose of the Clinical Study\]:The purpose of this study is to conduct a clinical comparison of low-dose rosuvastatin plus ezetimibe combination therapy and high-dose...

Sponsor: Saint Vincent's Hospital, KoreaEnrolling: 63561 location
RECRUITINGNCT05644548

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Hypertension, diabetes mellitus, and dyslipidemia are common internal diseases, and all diseases are atherosclerosis risk factors. Previous studies applied color fundus...

Sponsor: Beijing Tongren HospitalEnrolling: 3001 location
RECRUITINGNCT05881447

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

Chronic kidney disease (CKD) is associated with increased cardiovascular morbidity and mortality. The prevalence of CKD is increasing worldwide and is assumed to also dramatically...

Sponsor: Swiss Tropical & Public Health InstituteEnrolling: 12001 location
RECRUITINGNCT06409962

A New Technological Intervention to Address Childhood Obesity:

Childhood obesity is a global public health issue, with rising prevalence rates. In Spain, the problem is significant, particularly in the southern regions. Factors contributing...

Sponsor: Universidad de CórdobaEnrolling: 2151 location
RECRUITINGNCT05949879

Dose Response Effects of Pecan Consumption

The bioactive compounds contained in tree nuts have been shown to beneficially affect cardiometabolic health outcomes. Pecans contain more total phenols, sterols, and flavonoids...

Sponsor: University of GeorgiaEnrolling: 801 location
RECRUITINGPhase 2 / Phase 3NCT06220266

Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women

The goal of this clinical trial is to learn about the effects of phytoestrogen from Pueraria Mirifica in improvement of serum lipid parameters. The primary question it aims to...

Sponsor: Dhurakij Pundit UniversityEnrolling: 101 location
RECRUITINGNCT05988866

Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels

The goal of this clinical trial is to find out if lipodia, a digital health intervention, can help lower cholesterol levels and improve other health measures in adults with high...

Sponsor: Gaia AGEnrolling: 2721 location
RECRUITINGNCT05962372

Culturally Adapted Dietary Clinical Trial in PR

This project will determine whether a diet culturally adapted to adults in Puerto Rico can effectively decrease cardiometabolic risk factors. This will help define a...

Sponsor: Harvard School of Public Health (HSPH)Enrolling: 2501 location
RECRUITINGNCT07083206

A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

The objective of this study is to evaluate the effectiveness and safety of Pitavastatin/Ezetimibe FDC in patients with hypercholesterolemia.

Sponsor: Ahn-Gook Pharmaceuticals Co.,LtdEnrolling: 45001 location
RECRUITINGPhase 1NCT07491172

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

This is a single-arm, open-label, multicenter, ascending dose Phase 1 trial that will enroll participants 18 to 75 years of age with dyslipidemias that are refractory to available...

Sponsor: CRISPR Therapeutics AGEnrolling: 9018 locations
RECRUITINGPhase 3NCT06568471

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

This randomized study is to assess LDL-C reductions at Week 12 with monthly (Q4W \[≤31 days\]) dosing of HST101 (lerodalcibep) 300 mg administered subcutaneously (SC) compared to...

Sponsor: Hasten Biopharmaceutical Co., Ltd.Enrolling: 21018 locations